Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Biotech
J&J neuroscience drugs take spotlight with lofty revenue goals
Johnson and Johnson's global therapeutic head for neuroscience affirmed that the company is not interested in psychedelic partnerships.
Max Bayer
Dec 5, 2023 3:38pm
J&J drops $400M to acquire novel stroke-reducing heart implant
Nov 30, 2023 10:30am
Volatile day for CAR-T biotechs after FDA reveals safety review
Nov 28, 2023 4:35pm
J&J's DePuy Synthes aids in world's first whole-eye transplant
Nov 10, 2023 2:40pm
J&J to put surgical robot up for US clinical trials in late 2024
Nov 7, 2023 8:00am
Longtime BioMarin CEO hands off baton—Chutes & Ladders
Nov 3, 2023 9:30am
